Cargando…

Development of Small RNA Delivery Systems for Lung Cancer Therapy

RNA interference (RNAi) has emerged as a powerful tool for studying target identification and holds promise for the development of therapeutic gene silencing. Recent advances in RNAi delivery and target selection provide remarkable opportunities for translational medical research. The induction of R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, Yu, Kuwano, Kazuyoshi, Ochiya, Takahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394474/ https://www.ncbi.nlm.nih.gov/pubmed/25756380 http://dx.doi.org/10.3390/ijms16035254

Ejemplares similares

The Impact of Extracellular Vesicle-Encapsulated Circulating MicroRNAs in Lung Cancer Research
por: Fujita, Yu, et al.
Publicado: (2014)

RNAi Therapeutic Platforms for Lung Diseases
por: Fujita, Yu, et al.
Publicado: (2013)

Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer
por: Fujita, Yu, et al.
Publicado: (2015)

Extracellular vesicle-mediated cellular crosstalk in lung repair, remodelling and regeneration
por: Kadota, Tsukasa, et al.
Publicado: (2022)

Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases
por: Fujita, Yu, et al.
Publicado: (2018)

A novel platform to enable inhaled naked RNAi medicine for lung cancer
por: Fujita, Yu, et al.
Publicado: (2013)

Extracellular Vesicles in Chronic Obstructive Pulmonary Disease
por: Kadota, Tsukasa, et al.
Publicado: (2016)

The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer
por: Fujita, Yu, et al.
Publicado: (2015)

Chaperone‐mediated autophagy receptor modulates tumor growth and chemoresistance in non–small cell lung cancer
por: Ichikawa, Akihiro, et al.
Publicado: (2020)

Extracellular vesicle transfer of cancer pathogenic components
por: Fujita, Yu, et al.
Publicado: (2016)

Extracellular vesicles in smoking-related lung diseases
por: Fujita, Yu, et al.
Publicado: (2015)

Human bronchial epithelial cell‐derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF‐β‐WNT crosstalk
por: Kadota, Tsukasa, et al.
Publicado: (2021)

MicroRNA and liver cancer
por: Onishi, Masaya, et al.
Publicado: (2020)

Synthetic Lethality in Lung Cancer—From the Perspective of Cancer Genomics
por: Shimomura, Iwao, et al.
Publicado: (2019)

Development of miRNA‐based therapeutic approaches for cancer patients
por: Takahashi, Ryou‐u, et al.
Publicado: (2019)

Suppression of autophagy by extracellular vesicles promotes myofibroblast differentiation in COPD pathogenesis
por: Fujita, Yu, et al.
Publicado: (2015)

Can Extracellular Vesicles as Drug Delivery Systems Be a Game Changer in Cardiac Disease?
por: Okamura, Akihiko, et al.
Publicado: (2022)

A paradigm shift for extracellular vesicles as small RNA carriers: from cellular waste elimination to therapeutic applications
por: Hagiwara, Keitaro, et al.
Publicado: (2013)

Genetic Networks Lead and Follow Tumor Development: MicroRNA Regulation of Cell Cycle and Apoptosis in the p53 Pathways
por: Otsuka, Kurataka, et al.
Publicado: (2014)

Role of chaperone-mediated autophagy in the pathophysiology including pulmonary disorders
por: Hosaka, Yusuke, et al.
Publicado: (2021)

Cross-talk between cancer cells and their neighbors via miRNA in extracellular vesicles: an emerging player in cancer metastasis
por: Kogure, Akiko, et al.
Publicado: (2019)

Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
por: Miele, Evelina, et al.
Publicado: (2012)

The small vesicular culprits: the investigation of extracellular vesicles as new targets for cancer treatment
por: Urabe, Fumihiko, et al.
Publicado: (2017)

Mechanisms of Resistance to EGFR TKIs and Development of a New Generation of Drugs in Non-Small-Cell Lung Cancer
por: Kosaka, Takayuki, et al.
Publicado: (2011)

Unraveling the Mystery of Cancer by Secretory microRNA: Horizontal microRNA Transfer between Living Cells
por: Kosaka, Nobuyoshi, et al.
Publicado: (2012)

Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
por: Mirzaei, Sepideh, et al.
Publicado: (2021)

Stimuli-Responsive Drug Delivery Systems for the Diagnosis and Therapy of Lung Cancer
por: Lin, Xu, et al.
Publicado: (2022)

New insights into small‐cell lung cancer development and therapy
por: Wang, Yuwen, et al.
Publicado: (2020)

Emerging roles of long non‐coding RNA in cancer
por: Sanchez Calle, Anna, et al.
Publicado: (2018)

Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy
por: Wang, Yusi, et al.
Publicado: (2022)

A Challenge to Aging Society by microRNA in Extracellular Vesicles: microRNA in Extracellular Vesicles as Promising Biomarkers and Novel Therapeutic Targets in Multiple Myeloma
por: Yamamoto, Tomofumi, et al.
Publicado: (2018)

Recent Developments in Nanoparticle-Based siRNA Delivery for Cancer Therapy
por: Lee, Jong-Min, et al.
Publicado: (2013)

Targeted therapies in development for non-small cell lung cancer
por: Reungwetwattana, Thanyanan, et al.
Publicado: (2013)

miRNA signaling networks in cancer stem cells
por: Yoshida, Kosuke, et al.
Publicado: (2021)

Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy
por: Mainini, Francesco, et al.
Publicado: (2020)

Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer
por: Zaborowska-Szmit, Magdalena, et al.
Publicado: (2020)

Small interfering RNA for cancer treatment: overcoming hurdles in delivery
por: Charbe, Nitin Bharat, et al.
Publicado: (2020)

Intercellular crosstalk between cancer cells and cancer-associated fibroblasts via extracellular vesicles
por: Naito, Yutaka, et al.
Publicado: (2022)

Newly developed anti-angiogenic therapy in non-small cell lung cancer
por: Qu, Jingjing, et al.
Publicado: (2017)

Interactions between cancer cells and normal cells via miRNAs in extracellular vesicles
por: Nishida-Aoki, Nao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ru44dvlkv2j8bln2bosurdb149